GE HealthCare Faces $500M Revenue Impact from Tariffs in 2025
GE HealthCare recently reported strong Q1 2025 earnings, but warned of a significant tariff impact expected later in the year. Despite tariff pressures, the company
GE HealthCare recently reported strong Q1 2025 earnings, but warned of a significant tariff impact expected later in the year. Despite tariff pressures, the company
In a groundbreaking decision, the U.S. Food and Drug Administration (FDA) has approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform from Edwards Lifesciences
At ACC.25, new data from the EARLY TAVR trial reinforced the need for early intervention in asymptomatic severe aortic stenosis (AS), showing that timely TAVR
Edwards Lifesciences (NYSE: EW) has received FDA approval for its Sapien 3 TAVR system to treat severe aortic stenosis (AS) in asymptomatic patients, marking a
ResMed (NYSE: RMD) has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF), expanding its capabilities in virtual diagnostics for sleep, respiratory, and cardiac conditions.
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
